Life Water Berhad acquires Twinine
Published on: Fri, May 30, 2025 Text Size: Twinine recorded steady audited revenues of RM8.60 million in FY2022 and FY2023, and an unaudited RM8.50 million in FY2024, with a three-year average profit after tax (PAT) of RM0.91 million. Kota Kinabalu: Life Water Berhad, one of Sabah's leading beverage manufacturers, is taking a major leap beyond its core business with the RM10.5 million acquisition of Twinine Sdn Bhd, a seasoned player in the sauces and condiments market. Life Water Managing Director Liaw Hen Kong, said the move marks a significant milestone in Life Water's diversification strategy, while its core drinking water segment is set to grow by 40 percent with new production capacity coming online by the end of 2025. 'The acquisition was formalized via a Share Sale Agreement (SSA) to acquire 100 percent equity interest in Twinine, a company with over 35 years of experience and market presence across Sabah's West Coast, parts of Sarawak and Brunei,' he said in a statement. He said Twinine recorded steady audited revenues of RM8.60 million in FY2022 and FY2023, and an unaudited RM8.50 million in FY2024, with a three-year average profit after tax (PAT) of RM0.91 million. 'This is a strategic step forward in expanding our presence within the broader FMCG space. 'Twinine's product line complements our distribution capabilities, and we see clear potential to accelerate growth through cross-branding and tapping into shared consumer segments. We're particularly excited about bringing their products deeper into the East Coast of Sabah, where our existing network gives us a strong foothold,' he added.
Advertisement As part of its integration plan, he said, the company will introduce dual-shift operations at Twinine's existing facility to boost production. 'The Group is also exploring the establishment of a new manufacturing site at the Kota Kinabalu Industrial Park to support long-term growth in the condiments category. Twinine's founder will remain on board for two years to guide the transition and help drive expansion plans,' Liaw said. The acquisition is expected to enhance group earnings and accelerate Life Water's entry into new consumer markets under its broader fast-moving consumer goods (FMCG) strategy. The company also revealed that its core drinking water operations are on track for a 40 percent capacity increase by the end of 2025. Liaw said The Group's new Keningau plant, operational since early this year, has already added 59 million liters of annual production, pushing total capacity to 448 million liters per annum. Further expansion is underway at the Sandakan Sibuga Plant 1, where a new manufacturing line is being commissioned and expected to be completed in the second half of 2025. 'This will add another 178 million liters of annual capacity, raising the Group's total production to 626 million liters—a 40 percent increase compared to current levels,' he said. The company also announced its financial performance for the third quarter ended 31 March 2025 (Q3FY25), reporting RM43.12 million in revenue—up 0.95 percent from the previous quarter—driven by seasonal demand for carbonated and fruit beverages. Liaw emphasised that the drinking water segment remained the largest contributor, accounting for 82.6 percent of revenue. The Group achieved a gross profit (GP) of RM19.52 million with a GP margin of 45.3 percent, while profit before tax (PBT) was RM8.11 million and PAT stood at RM6.48 million. Margins slightly moderated due to the implementation of the minimum wage policy and temporary inefficiencies linked to expansion. For the nine-month period ended March 31, Life Water recorded RM128.42 million in revenue and RM20.97 million in PAT, maintaining a solid PAT margin of 16.3 percent. With a two-pronged strategy of organic growth and strategic diversification, Life Water is positioning itself as a rising multi-category FMCG player in East Malaysia. The Twinine acquisition enhances its product offerings and opens new growth channels, while the expanded production footprint ensures continued leadership in the bottled water space. Liaw said, as consumer demand evolves and competition intensifies, Life Water remains optimistic about its growth trajectory for FY2025 and beyond. * Follow us on our official WhatsApp channel and Telegram for breaking news alerts and key updates! * Do you have access to the Daily Express e-paper and online exclusive news? Check out subscription plans available.
Stay up-to-date by following Daily Express's Telegram channel. Daily Express Malaysia
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
5 hours ago
- The Sun
Pangaea Connectivity announced FY2025 Results: Revenue increased 53.8% to HK$2,128,200,000 driven by AI-Optimized Connectivity and Green Energy Technologies
HONG KONG SAR - EQS Newswire - 3 July 2025 - Pangaea Connectivity Technology Limited ('Pangaea' or the 'Company', together with its subsidiaries, the 'Group', stock code: 1473), a key player in the advanced connectivity segment, is pleased to announce its annual results for the fiscal year ended March 31, 2025. The Group achieved a historic milestone with record revenue of HK$2,128,200,000, representing a 53.8% year-on-year growth. This exceptional performance underscores the Group's success of its strategic initiatives and business focus in AI-optimized connectivity, renewable energy technologies, and next-generation wireless solutions, despite persistent global trade challenges. Three Core Technologies Fueling Growth The Group's success stems from three technological pillars: AI-Optimized Optical Connectivity, and High-Power Laser and Next-Gen Wireless Communication. Amid the explosive growth of artificial intelligence (AI) and high-performance computing (HPC), the Group's 800G/1.6T Linear-drive Pluggable Optics (LPO) technology solution has emerged as a game-changer. By eliminating power-hungry digital signal processing (DSP) chips found in traditional optical modules, LPO delivers power savings while maintaining ultra-low latency—making it a critical enabler for AI data center upgrades. The Xi'an Industrial Laser Service Center has developed to be a hub for supporting the innovation in high-power laser processing for solar back-contact (BC) battery manufacturing. Renewable energy technologies are advancing rapidly, particularly in solar BC battery manufacturing where the Group's high-power laser systems deliver unparalleled processing efficiency and precision working alongside the market existing generation of TOPCon (Tunnel Oxide Passivated Contact) and N-type technologies. The Group's early-mover advantage has recognized by leading global energy players. The same high-power laser innovations are also revolutionizing PCB and semiconductor manufacturing through faster, more energy-efficient processing. In wireless connectivity, the Group's pioneering WiFi8 products are expected to deliver multi-gigabit speeds, ultra-low latency, and enhanced network efficiency, making it ideal for smart factories, autonomous vehicles, and immersive digital experiences. By collaborating with leading suppliers and end users, the Group aims to be an early adopter and enabler of this transformative standard. Global Expansion Strengthens Supply Chain Resilience To navigate geopolitical challenges, the Group has expanded its smart logistics hubs in Wuhan and Shenzhen, enabling faster response times and reduced lead times for critical components. Our 24/7 technical support and maintenance services further strengthen customer trust and satisfaction. Southeast Asia represents a key growth market, with Singapore, Malaysia and Vietnam investing heavily in 5G/AI infrastructure, the Group has been engaging with few regional infrastructure developers. Outlook: Leading at the Nexus of AI and Green Energy Looking ahead, Pangaea's commitment to innovation, operational excellence, and supplier/customer collaboration ensures the Group is well-positioned to capitalize on the recent and upcoming trends. The technological expertise of the Gorup in the high-growth sectors - LPO for AI infrastructure, advanced high-power laser applications, and next-gen wireless – well positions the Group for sustainable long-term growth in the evolving tech landscape. Mr. Fung Yui Kong, Chairman, CEO, and Executive Director of Pangaea Connectivity Technology Limited, said, 'Our record performance proves the power of converging AI and green energy technologies, as we enter the 1.6T era for AI infrastructure and the mass adoption of BC solar technology, Pangaea is uniquely positioned to drive sustainable technological transformation.' The chairman emphasized that, 'Global AI data center growth has created unprecedented opportunities. We've actively advanced AI development, recognizing rising demand for AI-enabled communications devices in data centers and HPC environments. Our products meet AI's stringent requirements , and are driving innovation. As AI demand surges, our connectivity solutions play a pivotal role. Moving forward, we'll intensify investment to deliver high-performance, efficient and scalable products, strengthening our market leadership and technological edge.' About Pangaea Connectivity Technology Limited Founded in 1990, Pangaea Connectivity Technology Limited is an innovative technology company. The Company focuses on four major market sectors, namely AI HPC (High Performance Computing), Green Energy (Industrial Lasers), Wi-Fi and IoT Connectivity, and Telecommunication Infrastructure. In recent years, the Company has been actively involved in the field of artificial intelligence (AI) and green initiatives, and is committed to capitalizing on the rapidly evolving generative AI technologies to drive cross-industry transformative outcomes. Meanwhile, as part of its commitment to sustainability and green initiatives, the Company has pioneered the development and utilization of industrial laser processing technology for solar photovoltaic (PV) panels application.
Daily Express
15 hours ago
- Daily Express
Gas Malaysia Confirms the Lifting of Gas Curtailment
Published on: Thursday, July 03, 2025 Published on: Thu, Jul 03, 2025 Text Size: Gas Malaysia's pipeline network is a natural gas distribution system designed to safely deliver natural gas to end users across multiple sectors. SHAH ALAM: 025 – Gas Malaysia Berhad ('Gas Malaysia' or 'the Group'), a member of the MMC Group is pleased to announce that on 1 July 2025, it received an official confirmation from its gas supplier on the lifting of gas curtailment at Shah Alam and Batu Tiga City Gate stations, which had been imposed following the transmission pipeline fire incident at Putra Heights, Subang Jaya, Selangor. With this confirmation, gas supply has resumed in accordance with the quantities stipulated in the Gas Supply Agreements with customers. This achievement reflects the concerted efforts and close collaboration with all relevant stakeholders to ensure the safe delivery of gas. The Group places utmost importance on safety and will continue to uphold stringent operational standards to ensure that gas infrastructure development is carried out responsibly. Gas Malaysia's pipeline network is a natural gas distribution system designed to safely deliver natural gas to end users across multiple sectors. Operating at lower pressures and on a smaller scale than transmission pipelines, these pipelines are typically laid within road reserve areas, ensuring both accessibility and full compliance with regulatory standards. In line with its commitment to the safe and reliable delivery of gas, the Group also urges members of the public to remain vigilant and refrain from any activity that may compromise the safety of its gas pipelines, including unauthorised excavation work, open burning, placing obstructions along gas pipeline routes and related activities. Visible signboards and markers have been strategically placed along Gas Malaysia's pipeline pathways to alert both the general public as well as contractors about the presence of gas pipelines. In this regard, the Group would also like to express its sincere appreciation to all stakeholders, including its gas supplier, valued customers and related parties for their continued support, patience and cooperation throughout this curtailment period. For further information or to report any potential abnormalities, suspicious activities, or safety concerns near Gas Malaysia's pipeline infrastructure, kindly contact 1-800-88-9119. For general enquiries, please reach out to Gas Malaysia's Customer Service at 1-300-88-4276 or visit our website at * Follow us on our official WhatsApp channel and Telegram for breaking news alerts and key updates! * Do you have access to the Daily Express e-paper and online exclusive news? Check out subscription plans available. Stay up-to-date by following Daily Express's Telegram channel. Daily Express Malaysia
The Sun
a day ago
- The Sun
Drug & Medical Device & Aesthetics, 肌顏態 was displayed at the CSD2025, The GeneQueens and 金因敷 launch was grandly held in Changsha
HONG KONG SAR - EQS Newswire - 2 July 2025 - On June 27, 2025, Uni-Bio Science Group Limited (the 'Group')grandly held a new medical aesthetics product launch event in Changsha, releasing the high-end series GeneQueens of 肌顏態® and the medical device brand 金因敷®. Many experts, KOLs and partners attended the event. This launch not only showcased the Group's achievements in R&D, but also marked the comprehensive layout in the 'drug, medical device and Aesthetics' field. 1、 High-end medical aesthetics: GeneQueens series At the launch, the Group unveiled the high-end series of 肌顏態® -——GeneQueensTM (Human-Sequence Triple Protein Repair & Balance Ampoule). which functions on skin repair and anti-aging. By activating cell regeneration, it helps users restore their youthful and healthy skin condition. GeneQueensTM sets a new standard for anti-aging and repair by adding three core ingredients in sufficient quantities. Skbrella FN, as a key ingredient for cell repair, can accelerate the healing of skin wounds and promote the adhesion and migration of new cells. III Collagen strongly fills the skin structure, significantly enhancing elasticity and firmness. XVII Collagen can strengthen the connection between the epidermis and dermis, and consolidate the youthful foundation of the skin. In addition, GeneQueens adopts a sterile and preservative-free formula, relying on high-purity raw materials and patented technology, providing users with an 'instant enjoyment' precise and efficient experience. Its unique formula and outstanding efficacy were highly recognized by many experts on the spot. 2、金因敷 showcased a variety of new products Meanwhile, the Group also launched several new products of its medical device brand - 金因敷®, focusing on the professional repair field of medical aesthetics. 金因敷® complies with strict clinical trials and quality inspections to ensure its safety and effectiveness. The product adopts a high-purity non-allergenic formula, which can moisturize and accelerate wound repair. It also uses an exclusive cooling technology to relieve postoperative swelling and pain, providing a professional solution for sensitive skin and post-medical procedure care. 3、The latest research data was presented at CSD2025 It is worth mentioning that 肌顏態® also showcased the research data of 'The Efficacy Study of Fibronectin in the Repair of Skin Barrier Damage for the post-medical procedure' jointly conducted with the Cosmetics Testing Center of the Dermatology Hospital of Southern Medical University in the poster area of the 30th Academic Conference of the Chinese Medical Association (CSD2025). This is not only an endorsement of the Group's research capabilities, but also provides experts and scholars in the industry with an opportunity to gain a deeper understanding of the 肌顏態® technology and products. As an annual grand event in the field of dermatology and venereology in China, CSD2025 brings together authoritative experts and scholars in dermatology across the country, presenting multi-dimensional academic achievements and exchanges of ideas. The poster area is one of the core venues of the academic annual conference. Posters are not only an important way for researchers to showcase their scientific research achievements, but also a key link in promoting the dissemination of academic ideas and the feedback of clinical practice. 4、Academic speeches by several experts Several clinical experts at the launch further recognized the significant clinical value of 肌顏態® and 金因敷®. The experts highlighted that 肌顏態®' s patented ingredient, Skbrella FN, demonstrates immense potential in improving damaged sensitive skin barriers, reducing inflammatory erythema, alleviating discomfort sensations such as burning, tightness and itching, as well as enhancing post-laser repair and healing. In the clinical observations over the past few months, many patients treated with 肌顏態® have achieved remarkable therapeutic effects. The symptoms of anesthetic allergy have been rapidly relieved, the inflammatory pigmentation post-laser has significantly improved, the skin barrier has been repaired, and the patient satisfaction rate is extremely high. 金因敷® can effectively reduce redness, swelling and pain for post-medical procedures, accelerate wound healing and shorten the recovery time. Photo 1: 肌顏態 use case sharing by Professor Shi Ge, Director of the Department of Plastic Surgery of the Sixth Affiliated Hospital of Sun Yat-sen University; Photo 2: 肌顏態 use case sharing by Professor Ge Lan, from The First Affiliated Hospital of Army Medical University; Photo 3: Fibronectin clinical trial results sharing by Professor Ye Li, Head of Cosmetics Testing Center at Dermatology Hospital of Southern Medical University; Photo 4: Mr. Du Wei, CEO of Cosmetics News & Cosmetics Business Online, analyzes cosmetics industry development trends 6、The signing ceremony reflects the market potential Mr. Zhao Zhigang, CEO of Uni-Bio Science Group, emphasized: ' We have always adhered to the standards of biopharmaceuticals in creating skin care products. The release of GeneQueens and 金因敷 is an important milestone in building the 'Drugs, Medical device and Aesthetics' strategy and creating a full-cycle skin care solution, aiming to meet consumers' increasingly refined skin health needs. ' Furthermore, Ms. Liu Yihua, President of Global Cosmetics Group, attended the launch as an important guest. Uni-Bio Science Group and Global Cosmetics Group have jointly established a medical research co-creation biological platform. Utilizing gene-editing biosynthesis technology, the platform has launched Skbrella FN – a highly bioactive recombinant human fibronectin known as '皮優理'. The launch also witnessed a grand strategic signing ceremony. The Group has achieved in-depth cooperation with many well-known medical aesthetics chain institutions and well-known agents. This signing is not only a high recognition of the quality and market potential of GeneQueens and 金因敷®, but also a key step for the Group to accelerate commercialization and expand channels. Through strong alliances with leading channel partners, the Group will reach the core consumers and ensure the rapid release of huge commercial value. The successful holding of this launch not only marks a crucial step for the Group in medical aesthetics and medical devices, but also demonstrates the Group's in-depth layout and forward-looking vision in the 'Drugs, Medical device and Aesthetics' strategy. In the future, the Group will continue to be guided by technology and oriented towards clinical value, accelerate product innovation and technological upgrading, constantly enrich pipeline, and meet the growing market demands.
